section name header

Introduction

Acute coronary syndrome (ACS) is an emergent situation characterized by an acute onset of myocardial ischemia that results in myocardial death (i.e., myocardial infarction [MI]) if definitive interventions do not occur promptly. (Although the terms coronary occlusion, heart attack, and myocardial infarction are used synonymously, the preferred term is myocardial infarction.) The spectrum of ACS includes unstable angina, non-ST-segment elevation MI (NSTEMI), and ST-segment elevation MI (STEMI).

Pathophysiology

In unstable angina, blood flow in a coronary artery is reduced, often caused by the rupture of an atherosclerotic plaque. A clot begins to form, but the artery is not completely occluded. This is an acute situation that can result in chest pain and other symptoms and is sometimes referred to as preinfarction angina because the patient will likely have an MI if prompt interventions do not occur.

In an MI, plaque rupture and subsequent thrombus formation result in complete occlusion of the artery, leading to ischemia and necrosis of the myocardium supplied by that artery. Vasospasm (sudden constriction or narrowing) of a coronary artery, decreased oxygen supply (e.g., from acute blood loss, anemia, or low blood pressure), and increased demand for oxygen (e.g., from a rapid heart rate, thyrotoxicosis, or ingestion of cocaine) are other causes of MI. In each case, a profound imbalance exists between myocardial oxygen supply and demand. The area of infarction develops over minutes to hours; the expression “time is muscle” reflects the urgency of appropriate treatment to improve patient outcomes. An MI may be defined by the type, the location of the injury to the ventricular wall (anterior, inferior, posterior, or lateral wall), or by the point in time in the process of infarction (acute, evolving, old).

Clinical Manifestations

In many cases, the signs and symptoms of MI cannot be distinguished from those of unstable anginahence, the evolution of the term acute coronary syndrome.

Assessment and Diagnostic Findings

Medical Management

The goals of medical management are to minimize myocardial damage, preserve myocardial function, and prevent complications such as lethal dysrhythmias and cardiogenic shock.

Pharmacologic Therapy!!navigator!!

  • Nitrates (nitroglycerin) to increase oxygen supply via vasodilation
  • Anticoagulants (aspirin, unfractionated or low-molecular-weight heparin) to prevent clot formation
  • Analgesic agents (morphine sulfate) to reduce pain and anxiety and to decrease workload of the heart
  • Angiotensin-converting enzyme (ACE) inhibitors to decrease blood pressure and reduce oxygen demand of the myocardium or, if ACE inhibitors not appropriate, an angiotensin receptor blocker (ARB)
  • Beta-blocker if needed initially for dysrhythmias, or introduced within 24 hours of admission if not needed initially
  • Thrombolytic medications (alteplase [t-PA, Activase] and reteplase [r-PA, TNKase]): must be given as early as possible after the onset of symptoms, generally within 30 minutes of arrival; may be initiated when timely access to PCI therapy is not available

Emergent Percutaneous Coronary Intervention!!navigator!!

  • Patient with STEMI may be taken to the cardiac catheterization laboratory for an emergent PCI, usually within 60 minutes after arrival to the facility.
  • PCI treats the underlying atherosclerotic lesion via balloon angioplasty, placement of stents, atherectomy, or brachytherapy to open the occluded vessel.

Outline

Nursing Process


Outline